1010-14: Cannabinoids Overview: Medical Use, Abuse, Pharmacotherapy, and Assessment of Consequences
Select a Webinar Format:
 On-Demand Audio Recording
       $15.00 for APNA Members
       $25.00 for Non-Members

 
In order to register, you must log in. Use the login form at the top of the left-hand column.

1010: Cannabinoids Overview: Medical Use, Abuse, Pharmacotherapy, and Assessment of Consequences

 

Speaker: Christian J. Teter, PharmD, BCPP  Associate Professor of Psychopharmacology, College of Pharmacy, University of New England

 

Disclosures: Discussion of off-label uses will take place during this presentation. The speaker and the activity planners have no conflicts of interest to disclose.

 

Session Length: 90 minutes


Target Audience: RN, APRN

 

Session Objectives
Upon completion of this presentation, the participant will be able to:
1. Explain the mechanisms of action and pharmacodynamic properties of the cannabinoids (CB).
2. Support your decision to promote or deny medical MJ use in a patient based on efficacy studies that have assessed medical MJ use for the treatment of various medical and psychiatric disorders.
3. Recognize the role of pharmacy and nursing in the current medical marijuana climate.
4. Plan the medication management of CB use disorders in a patient based upon clinical presentation, signs and symptoms, diagnostic criteria, and the pharmacotherapy evidence-base for the treatment of CB use disorders.

 

Key words: TCH, Cannabinoids, Medical Marijuana, psychopharmacology

 

Continuing Nursing Education
1.5 contact hours. * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. We cannot award credit unless all steps are completed.

The content of this CNE activity pertains to pharmacology. Because states' requirements may vary, contact your Board of Nursing for more information.

The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

 

Originally Presented
APNA 12th Annual Clinical Psychopharmacology Institute | Reston, Virginia
Saturday, June 21, 2014
1:45pm 3:15pm

 

Release Date: July 21, 2014
The contact hours for this session expire: July 31, 2016


 

The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.